AstraZeneca has breached the UK pharmaceutical industry's code of practice, an industry self-regulatory body ruled on Friday, ...

Fundamental changes in asthma management are all geared to breaking the inhalers-antibiotics-inhalers-steroids cycle ...

KalVista Pharmaceuticals, Inc. (Nasdaq: KALV) today announced the acceptance of one abstract for late-breaking oral ...

In bronchiectasis, highly symptomatic patients have a greater risk of exacerbations and may benefit from long-term macrolide treatment.

More than 31 million people in the U.S. live with eczema, a chronic skin condition that can disrupt daily life yet continues ...

Eczema treatments have flourished in the last few years, meaning no one should have to suffer without relief. Eczema is a ...

A powerful new drug combo has yielded a major breakthrough for men battling an aggressive form of prostate cancer, ...

AstraZeneca has breached the UK pharma industry's code of practice with a claim on its website for asthma drug Symbicort, ...

Treatment for chronic hives lasting at least 6 weeks may include one or more types of medication, as well as certain ...

For decades, traditional adrenaline auto-injectors (AAIs) have been the only available treatment for anaphylaxis—a life-threatening allergic reaction.1,2 Yet from today, the UK’s first needle-free ...

In over 70,000 pediatric surgeries, many children went without clear liquids for double the recommended fasting time, raising ...